By ReutersPublished: 10:23 EDT, 18 April 2021 | Updated: 11:53 EDT, 18 April 2021AstraZeneca will have adapted its vaccine to combat the South African variant of Covid by the end of the year, the company's boss of Austrian operations has said. 'But we developed a vaccine, built a global supply chain, and received approvals in over 70 countries in less than 10 months. The Kurier interview did not directly address ongoing investigations into health concerns over the AstraZeneca shot. The EU has put a warning label on the vaccine over its possible linkage to extremely rare blood clots. British and European Union medicine regulators have said that the overall benefits of using the vaccine outweigh any risks.

Source: The Nation April 18, 2021 16:05 UTC